Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
Stabilization and time-critical threats
Airway compromise concerns
Facial trauma with airway risk
Anaphylaxis or angioedema mimics
Sepsis physiology
Hypotension
Altered mental status
Vision-threatening infection risk
Orbital cellulitis features
Intracranial extension features
Rapid distinction preseptal vs orbital
Orbital involvement screen
Pain with extraocular movements
Orbital cellulitis until proven otherwise
Imaging trigger when present
Ophthalmoplegia or restricted motility
High-risk for orbital compartment processes
Urgent ophthalmology involvement
Proptosis
Orbital cellulitis or abscess consideration
Emergent imaging and IV antibiotics
Decreased visual acuity or color desaturation
Optic nerve compromise concern
Immediate escalation pathway
Relative afferent pupillary defect
Post-septal pathology concern
Emergent specialist evaluation
Early escalation and consultation
Team activation and consults
Ophthalmology consult criteria
Any orbital signs
Vision change
Uncertain exam reliability
ENT consult criteria
Sinusitis with severe symptoms
Suspected subperiosteal abscess
Transfer criteria
Pediatric patient needing specialty coverage
Lack of CT or ophthalmology availability
History
Symptom characterization
Presenting syndrome
Eyelid swelling and erythema
Unilateral predominance
Rapid progression timeline
Pain pattern
Eyelid tenderness
Pain with eye movement
Visual symptoms
Blurry vision
Diplopia
Systemic symptoms
Fever
Malaise
Source and risk factors
Predisposing sources
Recent upper respiratory infection
Sinus symptoms
Purulent nasal discharge
Local skin disruption
Insect bite
Facial abrasion or laceration
Ocular surface infection history
Conjunctivitis
Hordeolum or chalazion
Dental infection history
Maxillary tooth pain
Recent dental procedure
Trauma exposures
Orbital fracture concern
Foreign body concern
Host factors
Diabetes mellitus
Increased severe infection risk
Consider broader coverage
Immunocompromise
Neutropenia
Chronic steroids or biologics
MRSA risk
Prior MRSA infection or colonization
Close contact outbreaks
Vaccination status
Incomplete Hib immunization
Incomplete pneumococcal immunization
Physical Exam
Eye and periocular exam
Focused ocular assessment
Visual acuity
Baseline comparison if known
Any decrease as escalation trigger
Pupils
Relative afferent pupillary defect
Anisocoria pattern
Extraocular movements
Pain with movement
Restriction pattern
Proptosis assessment
Globe position asymmetry
Resistance to retropulsion if assessed
Conjunctiva and cornea
Chemosis
Corneal staining when indicated
Eyelids
Diffuse erythema and warmth
Fluctuance suggesting abscess
General and head and neck exam
Associated infection evaluation
Vital signs
Fever pattern
Tachycardia
Sinus and nasal exam
Facial sinus tenderness
Purulent nasal drainage
Oral and dental exam
Gingival swelling
Dental caries or abscess signs
Skin exam
Impetigo lesions
Periorbital trauma entry point
PITFALLS
Common diagnostic traps
Orbital cellulitis misclassified as periorbital cellulitis
Subtle motility pain early in disease
Limited exam in young children
Allergic edema mimicking infection
Itching prominence
Bilateral symmetry
Herpes zoster ophthalmicus missed
V1 dermatomal rash
Hutchinson sign
Differential Diagnosis
Vision-threatening and time-sensitive causes
Critical ocular infections and complications
Orbital cellulitis
ICD-10 H05.0
Post-septal signs present
Subperiosteal abscess
SNOMED CT orbital subperiosteal abscess concept
Sinusitis association
Orbital abscess
SNOMED CT orbital abscess concept
Severe proptosis or ophthalmoplegia
Cavernous sinus thrombosis
ICD-10 I67.6
Cranial nerve deficits
Necrotizing soft tissue infection
ICD-10 M72.6
Disproportionate pain or skin necrosis
Common mimics and alternative diagnoses
Non-postseptal mimics
Allergic contact dermatitis
Itching
New topical exposure
Angioedema
Rapid swelling
Urticaria or airway symptoms
Hordeolum or chalazion
Focal eyelid nodule
Localized tenderness
Dacryocystitis
Medial canthus swelling
Nasolacrimal reflux
Herpes simplex eyelid infection
Vesicles
Recurrent history
Herpes zoster ophthalmicus
V1 rash
Neuropathic pain
Trauma-related entities
Preseptal hematoma
Clear trauma mechanism
Afebrile state
Orbital fracture with entrapment
Diplopia
EOM restriction without infectious signs
Laboratory Tests
Core labs when systemic illness or admission likelihood
Baseline and severity assessment
Complete blood count for systemic infection
Leukocytosis supportive but non-specific
Normal count does not exclude orbital disease
C-reactive protein for severity trend support
Elevated values support bacterial process
Trending useful when inpatient
Basic metabolic panel for IV therapy planning
Renal function for dosing
Electrolytes for dehydration or sepsis
Microbiology
Pathogen identification when feasible
Blood cultures for toxic appearance or sepsis physiology
Low yield in uncomplicated cases
Higher yield in severe pediatric cases
Purulent drainage culture if abscess or wound
MRSA detection for targeted therapy
Avoid superficial swab of intact skin
Additional labs in special contexts
Risk-tailored testing
Serum glucose for diabetes and severe infection risk
Hyperglycemia associated with worse outcomes
Treatment adjustment implications
Lactate for suspected sepsis
Elevated level supports hypoperfusion
Serial measurement for resuscitation response
Diagnostic Tests
Scoring Systems
Classification and severity frameworks
Chandler classification for orbital complications of sinusitis
Group 1 preseptal cellulitis
Group 2 orbital cellulitis
Group 3 subperiosteal abscess
Group 4 orbital abscess
Group 5 cavernous sinus thrombosis
Clinical orbit risk features bundle
Pain with extraocular movements
Ophthalmoplegia
Proptosis
Decreased visual acuity
MRI
MRI orbit and brain considerations
Indications
Suspected intracranial complication
Cavernous sinus thrombosis concern
Advantages
Superior soft tissue and intracranial detail
Better venous sinus evaluation with MRV
Limitations
Time and sedation barriers in pediatrics
Limited availability in emergent settings
CT
CT orbits and sinuses with IV contrast
Indications
Any orbital signs
Inability to perform reliable eye exam
Failure of appropriate antibiotics
Key findings
Postseptal fat stranding
Subperiosteal fluid collection
Orbital abscess
Interpretation pearls
Normal CT does not fully exclude early orbital cellulitis
Sinus opacification as common source clue
Ultrasound
Point-of-care ultrasound applications
Eyelid or facial soft tissue assessment
Abscess vs cellulitis differentiation in superficial tissue
Guidance for drainage planning when appropriate
Ocular ultrasound precautions
Avoid if globe rupture concern
Consider for optic nerve sheath diameter only in select contexts
Disposition
Level of care decisions
Admission criteria
Orbital signs present
IV antibiotics
Specialist evaluation
Toxic appearance or sepsis physiology
Parenteral therapy
Close monitoring
Immunocompromised host
Broader coverage
Lower threshold for imaging
Age-related risk
Infants and young children with unreliable exam
Social barriers to follow-up
Outpatient criteria
No orbital signs
Normal visual acuity
Full painless extraocular movements
Mild to moderate localized findings
No fluctuance requiring procedure
Stable vital signs
Reliable follow-up within 24 to 48 hours
Recheck plan documented
Clear return precautions
Transfer criteria
Higher level of care indications
Suspected abscess requiring surgical capability
Subperiosteal abscess concern
Orbital abscess concern
Need for pediatric subspecialty support
Ophthalmology unavailable
ENT unavailable
Treatment
Initial strategy and targets
Management pathway
Preseptal cellulitis without orbital signs
Oral antibiotics when mild and reliable follow-up
IV antibiotics when moderate to severe
Any orbital signs
IV antibiotics immediately
Imaging and specialty consultation
Source control considerations
Drainable abscess evaluation
Sinus disease management coordination
Oral antibiotic regimens
Outpatient antibiotics
Amoxicillin clavulanate PO
Adult dosing options
875 mg twice daily
500 mg three times daily
Pediatric dosing
45 mg/kg/day divided twice daily as amoxicillin component
High-dose 90 mg/kg/day divided twice daily when severe sinusitis features
Coverage targets
Streptococci
MSSA
Anaerobes from sinus sources
Cephalexin PO for skin-source features
Adult dosing
500 mg four times daily
1 g three times daily
Pediatric dosing
25 to 50 mg/kg/day divided 3 to 4 doses
Higher range for moderate severity
Coverage targets
Streptococci
MSSA
MRSA-active add-on when risk or purulence
Clindamycin PO
Adult dosing
300 to 450 mg three times daily
600 mg three times daily for severe infection
Pediatric dosing
20 to 30 mg/kg/day divided 3 doses
Max 450 mg per dose commonly used
Notes
Provides streptococcal coverage
Local resistance considerations
Trimethoprim sulfamethoxazole PO
Adult dosing
1 to 2 double-strength tablets twice daily
Double-strength tablet 160 mg TMP component
Pediatric dosing
8 to 12 mg/kg/day TMP component divided twice daily
Max dosing per local protocol
Combination need
Add beta-lactam for streptococcal coverage
Pair with amoxicillin clavulanate or cephalexin
Doxycycline PO for age-appropriate patients
Adult dosing
100 mg twice daily
Avoid in pregnancy
Pediatric restriction
Avoid under age 8 years
Alternative agents preferred
IV antibiotic regimens
Inpatient antibiotics
Ampicillin sulbactam IV
Adult dosing
3 g every 6 hours
Renal adjustment when indicated
Pediatric dosing
50 mg/kg per dose ampicillin component every 6 hours
Max 2 g ampicillin component per dose commonly used
Coverage targets
Streptococci
MSSA
Anaerobes
Ceftriaxone IV plus metronidazole IV for sinus and intracranial concern patterns
Ceftriaxone dosing
Adult 2 g daily
Pediatric 50 mg/kg daily to twice daily per severity
Metronidazole dosing
Adult 500 mg every 8 hours
Pediatric 7.5 mg/kg every 6 hours
Rationale
Gram-negative coverage
Anaerobic coverage
Vancomycin IV add-on for MRSA risk or severe infection
Adult dosing
15 to 20 mg/kg per dose every 8 to 12 hours
Trough or AUC-guided monitoring per local protocol
Pediatric dosing
15 mg/kg per dose every 6 hours commonly used
Monitoring for nephrotoxicity
Coverage targets
MRSA
Resistant gram-positive organisms
Clindamycin IV option when beta-lactam allergy
Adult dosing
600 to 900 mg every 8 hours
Monitor for C difficile risk
Pediatric dosing
10 mg/kg per dose every 8 hours
Max 900 mg per dose commonly used
Supportive care and adjuncts
Symptom and complication management
Analgesia
Acetaminophen dosing per weight
NSAID use when no contraindications
Hydration and perfusion support
Oral hydration when outpatient
IV fluids when sepsis physiology
Ophthalmic surface protection when exposure risk
Lubricating ointment
Moisture chamber in severe edema
Procedure and surgical pathways
Source control and operative considerations
Abscess drainage indications
Fluctuant eyelid abscess
Failure to improve on appropriate antibiotics
Subperiosteal abscess management collaboration
Ophthalmology involvement
ENT involvement
Orbital compartment syndrome concern
Rapid vision decline
Proptosis with tense orbit
Special Populations
Pregnancy
Pregnancy-specific considerations
Antibiotic selection
Avoid doxycycline
Beta-lactams preferred when appropriate
Imaging considerations
MRI preference when intracranial concern and feasible
CT risk-benefit when vision-threatening suspicion
Severity threshold
Lower threshold for admission with systemic illness
Maternal sepsis implications
Geriatric
Older adult considerations
Atypical presentation
Blunted fever response
Subtle mental status change
Medication safety
Renal dosing adjustments
Drug-drug interaction review
Complication risk
Higher necrotizing infection risk in diabetes
Lower threshold for imaging when exam limited
Pediatrics
Pediatric considerations
Exam reliability limitations
Pain with EOM hard to elicit
Visual acuity assessment challenges
Vaccination status relevance
Hib risk when unimmunized
Pneumococcal disease patterns
Admission threshold
Young age with moderate swelling
Inability to ensure 24-hour follow-up
Weight-based dosing safety
Max dose limits awareness
Concentration and formulation checks
Background
Epidemiology
Population patterns
Common pediatric facial infection presentation
Sinusitis as frequent antecedent
Skin trauma as frequent antecedent
Seasonal clustering
Higher incidence during viral URI seasons
Association with sinus infections
Microbiology patterns
Streptococcus species common
Staphylococcus aureus common
Pathophysiology
Anatomic and mechanistic concepts
Orbital septum as boundary
Preseptal infection confined anterior to septum
Postseptal infection involving orbit structures
Spread pathways
Contiguous spread from sinuses
Hematogenous spread in bacteremia
Complication mechanisms
Subperiosteal abscess from ethmoid sinusitis
Cavernous sinus thrombosis via venous drainage
Therapeutic Considerations
Treatment rationale
Early antibiotics to prevent postseptal progression
Lower threshold for IV therapy when high risk
Close reassessment within 24 to 48 hours
Empiric coverage targets
Streptococci coverage baseline
MSSA coverage baseline
MRSA coverage when risk factors present
Imaging timing
Immediate imaging when orbital signs present
Deferred imaging when classic mild preseptal and reliable follow-up
Patient Discharge Instructions
copy discharge instructions
Discharge instructions
Diagnosis explanation
Infection of eyelid tissues in front of the eye socket
Different from deeper orbital infection that can threaten vision
Medication plan
Antibiotics exactly as prescribed until finished
Do not skip doses
Symptom care
Warm compresses to eyelid for comfort
Acetaminophen or ibuprofen for pain if allowed
Follow-up plan
Recheck within 24 to 48 hours
Earlier recheck if symptoms worsen
Return to emergency immediately for any of the following
Pain when moving the eye
Double vision
Trouble moving the eye
Bulging eye appearance
New or worsening vision changes
Severe headache
High fever or worsening illness
Increasing swelling despite antibiotics
References
Clinical guidelines and evidence sources
Guideline and reference set
Infectious Diseases Society of America skin and soft tissue infection guidance
Empiric MRSA coverage principles in purulent cellulitis settings
Duration and reassessment principles
American Academy of Pediatrics Red Book guidance
Pediatric facial and periorbital infection antibiotic options
Vaccine-era organism considerations
American Academy of Ophthalmology clinical education resources
Orbital cellulitis warning signs
Imaging triggers and consult pathways
Otolaryngology guidance for complicated sinusitis
Subperiosteal abscess management pathways
Surgical consideration criteria
Coding and terminology
Medical coding references
ICD-10 periorbital cellulitis
L03.213 cellulitis of right periorbital region
L03.214 cellulitis of left periorbital region
L03.219 cellulitis of unspecified periorbital region
ICD-10 orbital cellulitis
H05.0 orbital cellulitis
Postseptal infection term alignment
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.